Evaluation test about safety and efficacy of the respiratory muscle training therapy by abdominal respiratory weight exercises in chronic cardiovascular disease patients

Evaluation test about safety and efficacy of the respiratory muscle training therapy by abdominal respiratory weight exercises in chronic cardiovascular disease patients - Respiratory muscle training therapy in chronic cardiovascular diseases

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000021661

Enrollment

Registered

2016-04-01

Start date

2016-04-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic cardiovascular disease

Interventions

The respiratory muscle training therapy is performed in addition to performing conventional cardiac rehabilitation. The respiratory muscle training therapy is abdominal muscle training method. Interv

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with chronic cardiovascular disease in outpatient or in hospital of Kurume University hospital Patients with informed consent Patients with chronic cardiovascular disease shown in the following Ischemic heart disease Valvular heart disease Hypertensive heart disease Cardiomyopathy Arrhythmia Adult congenital heart disease Pulmonary hypertension

Exclusion criteria

Exclusion criteria: Patients with obstructive respiratory disease Patients with the device planted Patients with difficult musculoskeletal disease Patients with symptoms at rest Patients with pulmonary hypertension of the WHO classification 3 more Patients with hypoxemia in spite of the use of breathing ancillary equipment Patients with uncontrolled high blood pressure Patients with poor control of arrhythmia, such as adverse effects on hemodynamics Patients that may be in or pregnancy Others, patients who are judged that this study is unsuitable by physician

Design outcomes

Primary

Measure	Time frame
Improvement of cardiac function	—

Secondary

Measure	Time frame
Improvement of respiratory function Improvement of exercise capacity Relief of symptoms Autonomic function Body composition Physical function Carbohydrate metabolism Lipid metabolism	—

Countries

Japan

Contacts

Public ContactMiki Biwa

Kurume University School of Medicine Division of Cardio-Vascular Medicine, Department of Internal Medicine

biwa_miki@med.kurume-u.ac.jp0942-31-7580

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026